A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

Phase 4 Recruiting 484 enrolled Myungmoon Pharma. Co. Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 750 mg administration in patients with Cholesterol gallstone (radiolucent gallstones)

Timeline

Start: 2025-07-28
Primary completion: 2026-06
Completion: 2026-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CnU	Unknown	250 mg	—
Comparator	Ursa	Unknown	200 mg	—

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

Summary

Timeline

Drugs

Indications